Germany-based BioNTech AG has appointed Sierk Pötting as its new chief financial officer succeeding Michael Kring who will remain as a member of the board of directors until the end of 2014. Mr Pötting was most recently CFO and vice president at Sandoz Inc (Novartis). He began his career as a consultant with McKinsey & Co after completing a degree and doing postdoctoral work in quantum physics.
BioNTech AG is developing immunotherapies against cancer.
The company announced the appointment on 1 September 2014.
Copyright 2014 Evernow Publishing Ltd